Table 2.
Antimicrobial resistance of pneumococcal isolates from children with CAP (n = 243) and HAP (n = 44).
| Agent (%) | CAP (N = 243) | HAP (N = 44) | TOTAL (N = 287) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| PSSP (n = 168) | PISP (n = 65) | PRSP (n = 10) | PSSP (n = 28) | PISP (n = 12) | PRSP (n = 4) | PSSP (n = 196) | PISP (n = 77) | PRSP (n = 14) | |
| SXT | 69.0 | 92.3 | 90.0 | 67.9 | 100 | 100 | 68.9 | 93.5 | 92.9 |
| ERY | 99.4 | 96.9 | 100 | 100 | 100 | 100 | 99.5 | 97.4 | 100 |
| CLI | 98.8 | 96.9 | 80.0 | 100 | 100 | 75.0 | 99 | 97.4 | 78.6 |
| VAN | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| LZD | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MXF | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SXT, sulfamethoxazole-trimethoprim; ERY, erythromycin; CLI, clindamycin; VAN, vancomycin; LZD, linezolid; MXF, moxifloxacin.